Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al
Br J Clin Pharmacol
.
2019 Jun;85(6):1380-1381.
doi: 10.1111/bcp.13924.
Epub 2019 Apr 13.
Authors
Solène M Laville
1
,
Bénédicte Stengel
1
,
Ziad A Massy
1
2
,
Sophie Liabeuf
3
Affiliations
1
CESP Centre for Research in Epidemiology and Population Health, Univ Paris-Saclay, Univ Paris Sud, UVSQ, UMRS 1018, Villejuif, France.
2
Nephrology Department, CHU Ambroise Pare, Boulogne, France.
3
Pharmacology department, Amiens University Hospital, Amiens, France.
PMID:
30980562
PMCID:
PMC6533517
DOI:
10.1111/bcp.13924
No abstract available
Publication types
Letter
Comment
MeSH terms
Allopurinol
Drug Prescriptions
Gout Suppressants
Gout*
Humans
Renal Insufficiency, Chronic*
Substances
Gout Suppressants
Allopurinol